Home・Aktien・Erasca Inc

Erasca Inc

Geschlossen

19.21 1.8

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

18.81

Max

19.22

Schlüsselkennzahlen
By Trading Economics
Einkommen	-154M -183M
EPS	-0.6
Angestellte	103
EBITDA	-151M -183M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+17.68% upside

Dividenden
By Acuity
Nächstes Ergebnis	10. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	2.3B 5.6B
Vorheriger Eröffnungskurs	17.41
Vorheriger Schlusskurs	19.21

Erasca Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Juli 2026, 23:51 UTC

Cryptocurrency Gains Amid Investor Shift from Gold, While Geopolitical Tensions and Economic Data Loom Over Financial Markets.

18. Juli 2026, 23:51 UTC

Bitcoin and Ethereum rise amid investor shift from gold, while geopolitical tensions and U.S. Treasury shifts signal potential market volatility ahead of key economic data releases.

18. Juli 2026, 23:51 UTC

Bitcoin and Ethereum rise as investors shift from gold amid market volatility, while U.S. labor participation hits a 50-year low and geopolitical tensions escalate in the Middle East.

18. Juli 2026, 23:51 UTC

Bitcoin and Ethereum gain momentum amid investor shift from gold, while geopolitical tensions and upcoming economic data influence market sentiment.

18. Juli 2026, 23:41 UTC

Canada's Retail Sales Ex Autos MoM report on July 23, 2026, forecasts modest growth at 0.4%, amid cautious market sentiment due to geopolitical tensions and economic uncertainties.

18. Juli 2026, 23:41 UTC

Chicago Fed National Activity Index Release on July 23, 2026, Expected to Reflect Economic Fluctuations Amid Geopolitical Tensions and Rising Oil Prices.

18. Juli 2026, 23:31 UTC

ECB Set to Raise Interest Rates Amid Rising Inflation Concerns Driven by Geopolitical Tensions on July 23, 2026.

18. Juli 2026, 23:31 UTC

Euro Area's Deposit Facility Rate Expected to Hold Steady at 2.25% Amid Geopolitical Tensions and Inflation Concerns

18. Juli 2026, 23:21 UTC

China's Loan Prime Rate (LPR) 1Y set for July 20, 2026 at a forecasted 0.03%, amid cautious investor sentiment and rising inflation concerns.

18. Juli 2026, 23:21 UTC

China's Loan Prime Rate Expected to Remain Steady at 3.50% for Five Years Amid Stable Market Sentiment

18. Juli 2026, 22:51 UTC

Japan's Inflation Rate YoY Release on July 23, 2026 Sparks Concerns Over Economic Pressures and Market Volatility Amid Rising Interest Rates.

18. Juli 2026, 22:51 UTC

Japan's Core Inflation Rate YoY Expected to Rise to 1.6% Amidst CFO Concerns Over Economic Pressures and Geopolitical Tensions

18. Juli 2026, 22:41 UTC

Mortgage Rates Hit Nine-Month High Amid Inflation Concerns and Cautious Market Sentiment Ahead of Upcoming Data Release.

18. Juli 2026, 22:41 UTC

Canada's Inflation Rate Expected to Drop Significantly Amid Geopolitical Tensions and Recent Price Declines

18. Juli 2026, 22:41 UTC

Canada's Inflation Rate Expected to Decline Slightly in June Amid Geopolitical Tensions and Volatile Market Conditions

18. Juli 2026, 22:41 UTC

Canada's Core Inflation Rate Release on July 20, 2026: Market Anticipates Lower Figures Amid Geopolitical Tensions and Recent CPI Drop.

18. Juli 2026, 22:31 UTC

Japan's June 2026 export growth forecasted at 0.186%, amid market volatility and geopolitical tensions impacting major exporters.

18. Juli 2026, 22:31 UTC

Japan's Balance of Trade report predicts a -120 billion yen deficit amid rising import costs and negative market sentiment, as stock indices decline due to global economic concerns.

18. Juli 2026, 22:31 UTC

Brazil's Central Bank to announce SELIC interest rate decision on July 20, 2026, amid stable market sentiment.

18. Juli 2026, 22:31 UTC

UK Consumer Confidence Expected to Decline to -21.0 Amid Rising Inflation and Geopolitical Tensions

18. Juli 2026, 22:21 UTC

Australia's S&P Global Services PMI Flash Release on July 23, 2026: Key Indicator Amid Mixed Market Sentiment and Inflation Concerns.

18. Juli 2026, 22:21 UTC

Optimism Grows Ahead of Australia's S&P Global Manufacturing PMI Flash Release Amid Strong Industrial Performance and Positive Investor Sentiment

18. Juli 2026, 22:11 UTC

Turkey's TCMB Expected to Maintain 37% Interest Rate Amid Inflation Pressures and Geopolitical Tensions on July 23, 2026.

18. Juli 2026, 22:01 UTC

South Korea's Q2 GDP Growth Rate Estimate Set for July 22 Amid Cautious Optimism and External Concerns.

18. Juli 2026, 22:01 UTC

South Korea's Upcoming GDP Growth Rate Release on July 22, 2026, Sparks Investor Anxiety Amid Geopolitical Tensions and Foreign Sell-Offs.

18. Juli 2026, 21:11 UTC

UK Factory Orders Forecasted at -40.0 Amid Mixed Sentiment and Economic Pressures Ahead of July 2026 Release

18. Juli 2026, 21:11 UTC

UK CBI Business Optimism Index for Q3 2026 set to reveal cautious optimism amid geopolitical tensions and inflationary pressures.

18. Juli 2026, 20:51 UTC

Correlated Moves

Macro News

Bitcoin is trading higher today amid rising geopolitical tensions and crude oil prices. Ethereum's movement reflects similar market dynamics in the cryptocurrency sector.

18. Juli 2026, 20:01 UTC

Macro News

Crude oil prices rose in after-market hours amid escalating geopolitical tensions affecting shipping routes, particularly following military actions involving Iran and U.S. forces.

18. Juli 2026, 20:01 UTC

API Crude Oil Stock Change Report Set for July 21, Amid Geopolitical Tensions Driving Price Volatility and Supply Concerns.

Peer-Vergleich

Kursveränderung

Erasca Inc Prognose

Kursziel

By TipRanks

17.68% Vorteil

12-Monats-Prognose

Durchschnitt 22.56 USD 17.68%

Hoch 30 USD

Tief 18 USD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Erasca Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

9 ratings

Buy

Halten

Sell

Basierend auf 9 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Erasca Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.